Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
Upcoming SlideShare
Loading in...5
×
 

Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

on

  • 133 views

 

Statistics

Views

Total Views
133
Views on SlideShare
133
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery Document Transcript

  • Australia Diabetes Care Devices Market Outlook to 2018-Glucose Monitoring and Insulin DeliveryReport Details:Published:September 2012No. of Pages: 85Price: Single User License – US$2500Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin DeliverySummaryGlobalData’s new report, “Australia Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin Delivery” provides key market data on the Australia Diabetes Care Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within two market categories – Glucose Monitoring and InsulinDelivery. The report also provides company shares and distribution shares data for each of theaforementioned market categories. The report is supplemented with global corporate-level profilesof the key market participants with information on company financials and pipeline products,wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the Australia Diabetes CareDevices market.- Key players covered include F. Hoffmann-La Roche Ltd., Novo Nordisk A/S , Sanofi , AbbottLaboratories , Eli Lilly and Company , Becton, Dickinson and Company and others.
  • Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Australia Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/197491-australia-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 51.2 List of Figures 62 Introduction 82.1 What is This Report About? 83 Diabetes Care Devices In Australia 93.1 Diabetes Care Devices, Market Segmentation 93.2 Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 103.3 Diabetes Care Devices Market, Australia, Revenue Mix ($m), 2011 113.4 Diabetes Care Devices Market, Australia, Category Contribution (%), 2011 123.5 Diabetes Care Devices, Australia, Company Share (2010-2011) 194 Glucose Monitoring In Australia 214.1 Glucose Monitoring, Market Segmentation 214.2 Glucose Monitoring Market, Australia, Revenue Mix ($m), 2011 224.3 Glucose Monitoring Market, Australia, Segment Contribution (%), 2011 234.4 Glucose Monitoring Overall Revenue, (2004-2018) 244.4.1 Blood Glucose Meters, Revenue (2004-2018) 284.5 Glucose Monitoring Overall Volume (2004-2018) 324.5.1 Blood Glucose Meters, Volume (2004-2018) 354.6 Glucose Monitoring Average Price (2004-2018) 384.7 Glucose Monitoring Distribution Share (2010-2011) 394.8 Glucose Monitoring, Australia, Company Share (2010-2011) 405 Insulin Delivery In Australia 425.1 Insulin Delivery, Market Segmentation 425.2 Insulin Delivery Market, Australia, Revenue Mix ($m), 2011 43
  • 5.3 Insulin Delivery Market, Australia, Segment Contribution (%), 2011 445.4 Insulin Delivery Overall Revenue, (2004-2018) 455.4.1 Insulin Pens, Revenue (2004-2018) 495.4.2 Insulin Pumps, Revenue (2004-2018) 535.5 Insulin Delivery Overall Volume (2004-2018) 555.5.1 Insulin Pens, Volume (2004-2018) 595.5.2 Insulin Pumps, Volume (2004-2018) 635.6 Insulin Delivery Average Price (2004-2018) 655.7 Insulin Delivery Distribution Share (2010-2011) 665.8 Insulin Delivery, Australia, Company Share (2010-2011) 676 Overview of Key Companies in Australia Diabetes Care Devices Market 696.1 F. Hoffmann-La Roche Ltd. 696.1.1 Company Overview 696.1.2 Share in the Australia Diabetes Care Devices Market 696.2 Novo Nordisk A/S 706.2.1 Company Overview 706.2.2 Share in the Australia Diabetes Care Devices Market 706.3 Sanofi 716.3.1 Company Overview 716.3.2 Share in the Australia Diabetes Care Devices Market 716.4 Abbott Laboratories 726.4.1 Company Overview 726.4.2 Share in the Australia Diabetes Care Devices Market 726.5 Eli Lilly and Company 736.5.1 Company Overview 736.5.2 Share in the Australia Diabetes Care Devices Market 736.6 Becton, Dickinson and Company 746.6.1 Company Overview 746.6.2 Share in the Australia Diabetes Care Devices Market 746.7 Bayer HealthCare AG 756.7.1 Company Overview 756.8 Medtronic, Inc. 756.8.1 Company Overview 756.9 ARKRAY, Inc. 766.9.1 Company Overview 766.10 Animas Corporation 766.10.1 Company Overview 766.11 B. Braun Melsungen AG 766.11.1 Company Overview 767 Diabetes Care Devices Market Pipeline Products 778 Appendix 808.1 Definitions of Markets Covered in the Report 81
  • 8.1.1 Diabetes Care Devices 818.2 Research Methodology 838.3 Secondary Research 838.4 Primary Research 848.5 Models 848.6 Forecasts 848.7 Expert Panels 858.8 GlobalData Consulting 858.9 Currency Conversion 858.10 Contact Us 858.11 Disclaimer 851.1 List of TablesTable 1: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 10Table 2: Diabetes Care Devices Market, Australia, Category Contribution (%), 2011 12Table 3: Diabetes Care Devices, Australia, Cross-Segment Analysis, 2004-2018 14Table 4: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16Table 5: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 18Table 6: Diabetes Care Devices, Australia, Company Share by Revenue ($m), USD Constant,2010-2011 20Table 7: Glucose Monitoring Market, Australia, Segment Contribution (%), 2011 23Table 8: Glucose Monitoring, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 25Table 9: Glucose Monitoring, Australia, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 27Table 10: Blood Glucose Meters, Australia, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 29Table 11: Blood Glucose Meters, Australia, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 31Table 12: Glucose Monitoring, Australia, Volume (Units) by Segment, Historic, 2004-2011 33Table 13: Glucose Monitoring, Australia, Volume (Units) by Segment, Forecast, 2011-2018 34Table 14: Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Historic, 2004-201135Table 15: Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Forecast, 2011-201837Table 15: Glucose Monitoring, Australia, Average Price ($), Historic, 2004-2011 38Table 16: Glucose Monitoring, Australia, Average Price ($), Forecast, 2011-2018 38Table 17: Glucose Monitoring, Australia, Distribution Share by Revenue ($m), USD Constant,2010-2011 39Table 18: Glucose Monitoring, Australia, Company Share by Revenue ($m), USD Constant, 2010-
  • 2011 41Table 19: Insulin Delivery Market, Australia, Segment Contribution (%), 2011 44Table 20: Insulin Delivery, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 46Table 21: Insulin Delivery, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 48Table 22: Insulin Pens, Australia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 50Table 23: Insulin Pens, Australia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 52Table 24: Insulin Pumps, Australia, Revenue ($m) USD Constant, Historic, 2004-2011 53Table 25: Insulin Pumps, Australia, Revenue ($m) USD Constant, Forecast, 2011-2018 54Table 26: Insulin Delivery, Australia, Volume (Units) by Segment, Historic, 2004-2011 56Table 27: Insulin Delivery, Australia, Volume (Units) by Segment, Forecast, 2011-2018 58Table 28: Insulin Pens, Australia, Volume (Units) by Sub-Segment, Historic, 2004-2011 60Table 29: Insulin Pens, Australia, Volume (Units) by Sub-Segment, Forecast, 2011-2018 62Table 30: Insulin Pumps, Australia, Volume (Units), Historic, 2004-2011 63Table 31: Insulin Pumps, Australia, Volume (Units), Forecast, 2011-2018 64Table 32: Insulin Delivery, Australia, Average Price ($), Historic, 2004-2011 65Table 33: Insulin Delivery, Australia, Average Price ($), Forecast, 2011-2018 65Table 34: Insulin Delivery, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 66Table 35: Insulin Delivery, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 68Table 36: Diabetes Care Devices Market Pipeline Products 771.2 List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 9Figure 2: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 10Figure 3: Diabetes Care Devices Market, Australia, Revenue Mix ($m), 2011 11Figure 4: Diabetes Care Devices Market, Australia, Category Contribution (%), 2011 12Figure 5: Diabetes Care Devices, Australia, Cross-Segment Analysis, 2004-2018 13Figure 6: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 15Figure 7: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Forecast,2011-2018 17Figure 8: Diabetes Care Devices, Australia, Company Share (%)-2011 19Figure 9: Glucose Monitoring, Market Segmentation 21Figure 10: Glucose Monitoring Market, Australia, Revenue Mix ($m), 2011 22Figure 11: Glucose Monitoring Market, Australia, Segment Contribution (%), 2011 23Figure 12: Glucose Monitoring, Australia, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 24
  • Figure 13: Glucose Monitoring, Australia, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 26Figure 14: Blood Glucose Meters, Australia, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 28Figure 15: Blood Glucose Meters, Australia, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 30Figure 16: Glucose Monitoring, Australia, Volume (Units) by Segment, Historic, 2004-2011 32Figure 17: Glucose Monitoring, Australia, Volume (Units) by Segment, Forecast, 2011-2018 34Figure 18: Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Historic, 2004-201135Figure 19: Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Forecast, 2011-2018 36Figure 19: Glucose Monitoring, Australia, Company Share (%), 2011 40Figure 20: Insulin Delivery, Market Segmentation 42Figure 21: Insulin Delivery Market, Australia, Revenue Mix ($m), 2011 43Figure 22: Insulin Delivery Market, Australia, Segment Contribution (%), 2011 44Figure 23: Insulin Delivery, Australia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 45Figure 24: Insulin Delivery, Australia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 47Figure 25: Insulin Pens, Australia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 49Figure 26: Insulin Pens, Australia, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 51Figure 27: Insulin Pumps, Australia, Revenue ($m) USD Constant, Historic, 2004-2011 53Figure 28: Insulin Pumps, Australia, Revenue ($m) USD Constant, Forecast, 2011-2018 54Figure 29: Insulin Delivery, Australia, Volume (Units) by Segment, Historic, 2004-2011 55Figure 30: Insulin Delivery, Australia, Volume (Units) by Segment, Forecast, 2011-2018 57Figure 31: Insulin Pens, Australia, Volume (Units) by Sub-Segment, Historic, 2004-2011 59Figure 32: Insulin Pens, Australia, Volume (Units) by Sub-Segment, Forecast, 2011-2018 61Figure 33: Insulin Pumps, Australia, Volume (Units), Historic, 2004-2011 63Figure 34: Insulin Pumps, Australia, Volume (Units), Forecast, 2011-2018 64Figure 35: Insulin Delivery, Australia, Company Share (%), 2011 67Figure 36: F. Hoffmann-La Roche Ltd., Company Share (%),Australia Diabetes Care DevicesMarket, 2011 69Figure 37: Novo Nordisk A/S, Company Share (%),Australia Diabetes Care Devices Market, 201170Figure 38: Sanofi, Company Share (%),Australia Diabetes Care Devices Market, 2011 71Figure 39: Abbott Laboratories, Company Share (%),Australia Diabetes Care Devices Market,2011 72Figure 40: Eli Lilly and Company, Company Share (%),Australia Diabetes Care Devices Market,2011 73
  • Figure 41: Becton, Dickinson and Company, Company Share (%),Australia Diabetes Care DevicesMarket, 2011 74Contact: sales@reportsandreports.com for more information.